[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,282
  • Shares Outstanding, K 46,839
  • Annual Sales, $ 8,980 K
  • Annual Income, $ -48,790 K
  • EBIT $ -52 M
  • EBITDA $ -52 M
  • 60-Month Beta 0.81
  • Price/Sales 4.45
  • Price/Cash Flow N/A
  • Price/Book 0.86
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.73
  • Most Recent Earnings $-0.16 on 05/04/26
  • Next Earnings Date 08/17/26 [BMO]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Options Overview Details

View History
  • Implied Volatility 506.76% (-107.37%)
  • Historical Volatility 41.53%
  • IV Percentile 63%
  • IV Rank 49.65%
  • IV High 991.35% on 08/03/26
  • IV Low 28.94% on 09/04/25
  • Expected Move (DTE 8) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 574
  • Open Int (30-Day) 571
  • Expected Range 0.8600 to 0.8600

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.20
  • Number of Estimates 1
  • High Estimate $-0.20
  • Low Estimate $-0.20
  • Prior Year $-0.26
  • Growth Rate Est. (year over year) +23.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6500 +32.31%
on 08/03/26
0.8670 -0.81%
on 08/10/26
+0.1400 (+19.44%)
since 07/10/26
3-Month
0.6300 +36.51%
on 06/26/26
1.2400 -30.65%
on 05/13/26
-0.3400 (-28.33%)
since 05/12/26
52-Week
0.6300 +36.51%
on 06/26/26
2.5650 -66.47%
on 10/06/25
-1.6600 (-65.87%)
since 08/12/25

Most Recent Stories

More News
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST)  – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

RXST : 7.06 (+0.28%)
KMTS : 28.00 (+0.36%)
NSPR : 0.8600 (+0.87%)
AXNX : 70.98 (+0.75%)
InspireMD Initiates CGUARDIANS II Clinical Trial for CGuard Prime Carotid Stent System

InspireMD enrolls first patient in CGUARDIANS II trial for CGuard Prime Stent System in TCAR procedures.Quiver AI SummaryInspireMD, Inc. has announced the enrollment of the first patient in its CGUARDIANS...

NSPR : 0.8600 (+0.87%)
InspireMD, Inc. Appoints Scott R. Ward to Board of Directors to Drive Stroke Prevention Innovation

InspireMD appoints Scott R. Ward to its Board, enhancing expertise ahead of potential U.S. approval for CGuard Prime stent.Quiver AI SummaryInspireMD, Inc. has announced the appointment of Scott R. Ward,...

NSPR : 0.8600 (+0.87%)
NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development

NAMSA , a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc . (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention...

NSPR : 0.8600 (+0.87%)

Business Summary

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous...

See More

Key Turning Points

3rd Resistance Point 0.9264
2nd Resistance Point 0.8932
1st Resistance Point 0.8766
Last Price 0.8600
1st Support Level 0.8268
2nd Support Level 0.7936
3rd Support Level 0.7770

See More

52-Week High 2.5650
Fibonacci 61.8% 1.8258
Fibonacci 50% 1.5975
Fibonacci 38.2% 1.3692
Last Price 0.8600
52-Week Low 0.6300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.